BVA seeks regional representatives
Representatives are encouraged to apply from every area of the veterinary profession.
The BVA is on the lookout for seven new regional representatives to put forward the views of its members to BVA Council.
Opportunities have opened up in London, North East England, the East Midlands, Yorkshire, Northern Ireland, the West Midlands and Wales.
Representatives are encouraged to apply from every area of the veterinary profession. However, the individual must live in that geographical region and have enough time to commit to gathering, disseminating and representing members’ opinions.
The spokesperson must also be available to attend three Council meetings each year at BVA’s Mansfield Street office in London and one at Members’ Day, the organisation said.
“The regional representatives are integral to BVA's working as they act as a bridge between our members across the UK and BVA’s policy and decision-making at Council level,” commented Gudrun Ravetz, president of the BVA.
“We appreciate feedback on how we shape and run BVA from all corners of the country, which wouldn’t be possible without the strong voices of the Reps in those regions.”
Ifan Lloyd, who steps down as Wales’ regional representative this year, added that he would encourage anyone with an interest to put their name forward.
“I’ve performed the role for six years and can honestly say that it's been a fantastic experience and a most fulfilling role,” he said.
“It's about giving something back to the profession but it's also an opportunity to broaden one's own horizons, get out to meet people and take advantage of the opportunity to make a difference.”
BVA members interested in becoming a representative for their area can apply before 18 December when nominations close. For more information or to speak to an existing representative please email council@bva.co.uk.
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
